ReviewClinical cancer research : an official journal of the American Association for Cancer Research2021
High-Specific-Activity-
Open access · bronzeAbstract readReview
In one paragraph
Review in Clinical cancer research : an official journal of the American Association for Cancer Research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
10.4field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
49 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.
- Response to targeted radionuclide therapy with [Frontiers in endocrinology · 2022Pooled it
- Phase II Study of ONC201 in Neuroendocrine Tumors including Pheochromocytoma-Paraganglioma and Desmoplastic Small Round Cell Tumor.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022Trial
- A case of metastasectomy following multiple courses of radionuclide therapy for distant metastatic pheochromocytoma.JCEM case reports · 2026Article
- Molecular imaging and radioligand therapies in pheochromocytomas and paragangliomas.Endocrine-related cancer · 2026Review
- Intracardiac paraganglioma in the left atrium in the context of a hereditary syndrome due to SDHD mutation: a case report.European heart journal. Case reports · 2026Article
- Precision imaging and evolving therapies in paragangliomas and pheochromocytomas: from molecular diagnostics to imaging-guided management.Insights into imaging · 2026Article
- Update on Systemic Therapies for Metastatic/Unresectable Pheochromocytomas and Paragangliomas and Future Directions.Cancers · 2025Review
- Expanding the therapeutic horizon ofNagoya journal of medical science · 2025Review
- Biofabrication of pheochromocytoma and paraganglioma tumor organoids and assessment of response to systemic therapy.Scientific reports · 2025Article
- Malignant paraganglioma of the kidney: a rare surgical case with 3-year disease-free survival.Journal of surgical case reports · 2025Article
- The Perioperative Biochemical and Clinical Considerations of Pheochromocytoma Management.International journal of molecular sciences · 2025Review
- The South AustralianESMO gastrointestinal oncology · 2025Article
- The Biochemical-Imaging Connection: Urinary Noradrenaline and Fluorodeoxyglucose-Positron Emission Tomography in Unresectable or Metastatic Pheochromocytomas and Paragangliomas.Diagnostics (Basel, Switzerland) · 2025Article
- Urinary Dopamine Levels Can Predict the Avidity of Post-Therapy [Pharmaceuticals (Basel, Switzerland) · 2025Article
- Bone metastases in pheochromocytomas and paragangliomas: a narrative review of presentation, diagnosis and management.Frontiers in endocrinology · 2025Review
- The Molecular Classification of Pheochromocytomas and Paragangliomas: Discovering the Genomic and Immune Landscape of Metastatic Disease.Endocrine pathology · 2024Review
- Primary Paraganglioma Arising From the Maxillary Bone.JCEM case reports · 2024Article
- Diagnostic performance of [European radiology · 2024Article
- Approach to the Patient: Concept and Application of Targeted Radiotherapy in the Paraganglioma Patient.The Journal of clinical endocrinology and metabolism · 2024Review
- Advances in Radioligand Theranostics in Oncology.Molecular diagnosis & therapy · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors at 20 institutions in 8 countries.
Abhishek JhaSection on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland.ORCID 0000-0002-1489-2471
David TaïebDepartment of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France.
Jorge A CarrasquilloDepartment of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0002-8513-5734
Daniel A PrymaDepartment of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Mayank PatelSection on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland.
Corina MilloDepartment of Positron Emission Tomography, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland.
Wouter W de HerderSection of Endocrinology, Department of Internal Medicine, ENETS Centre of Excellence, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands.ORCID 0000-0003-1463-5165
Jaydira Del RiveroDevelopmental Therapeutics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
Joakim CronaDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden.ORCID 0000-0003-0677-4894
Barry L ShulkinDepartment of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0003-4784-7914
Irene VirgoliniDepartment of Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria.
Alice P ChenDivision of Cancer Treatment and Diagnosis, NCI, NIH, Bethesda, Maryland.ORCID 0000-0002-1426-853X
Bhagwant R MittalDepartment of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Sandip BasuRadiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital Annexe, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
Joseph S DillonDepartment of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa.ORCID 0000-0002-4002-1418
Thomas A HopeDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, California.
Carina Mari ApariciDivisions of Nuclear Medicine and Molecular Imaging, Stanford University School of Medicine, Stanford, California.
Andrei H IagaruDivisions of Nuclear Medicine and Molecular Imaging, Stanford University School of Medicine, Stanford, California.ORCID 0000-0003-0839-5329
Rodney J HicksSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0002-0758-0824
Anca M AvramDivision of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-7940-9137
Jonathan R StrosbergDivision of Neuroendocrine Tumor/Department of Gastrointestinal Medicine, Moffitt Cancer Center, Tampa, Florida.
Ali Cahid CivelekDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology and Radiological Sciences, Johns Hopkins Medicine, Baltimore, Maryland.ORCID 0000-0003-4637-6292
Frank I LinMolecular Imaging Program, NCI, NIH, Bethesda, Maryland.
Neeta Pandit-Taskar *Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York. karel@mail.nih.gov pandit-n@mskcc.org.ORCID 0000-0003-1551-2036
Karel Pacak *Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, Maryland. karel@mail.nih.gov pandit-n@mskcc.org.
Eunice Kennedy Shriver National Institute of Child Health and Human Development · USMemorial Sloan Kettering Cancer Center · USNational Institutes of Health · USStanford University · USAix-Marseille Université · FRCenter for Cancer Research · USErasmus MC Cancer Institute · NLHomi Bhabha National Institute · INInnsbruck Medical University · ATItron (United States) · USJohns Hopkins University · USMoffitt Cancer Center · USPeter MacCallum Cancer Centre · AUPost Graduate Institute of Medical Education and Research · INSt. Jude Children's Research Hospital · USUniversity of California, San Francisco · USUniversity of Iowa Hospitals and Clinics · USUniversity of Michigan · USUniversity of Pennsylvania · USUppsala University · SE
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4MViral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0MPhase 2 study of Lu-177-DOTATATE in inoperable paraganglioma - pheochromocytoaZIABC011789 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LIN, FRANK · 2017 to 2025
$1.9MDiagnosis &Pathophysiology of PheochromocytomaZ01HD008735 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI PACAK, KAREL · 2001 to 2008
$1.7MPhase 12 study of Lu177-DOTATATE and olaparib in neuroendocrine tumorsZIABC011827 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LIN, FRANK · 2018 to 2025
$628kIntramural NIH HHS Z01 HD008735NCI NIH HHS P30 CA008748
Abstract
Targeted radionuclide therapies (TRT) using
Indexed as
3-IodobenzylguanidineAdrenal Gland NeoplasmsHumansIodine RadioisotopesLutetiumOctreotideOrganometallic CompoundsParagangliomaPheochromocytomaPositron Emission Tomography Computed TomographyRadioisotopesRadiopharmaceuticalsRadiotherapy3-IodobenzylguanidineIodine-131Iodine RadioisotopesLutetiumLutetium-177lutetium Lu 177 dotatateOctreotideOrganometallic CompoundsRadioisotopesRadiopharmaceuticals
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.